Profile data is unavailable for this security.
About the company
LBX Pharmacy Chain Joint Stock Company is a China-based company engaged in pharmaceutical retail chain operation. The Company involves in retailing drugs and other related products, including Chinese and Western medicines, prepared slices of Chinese crude drugs, health Chinese medicines, health equipment, healthy food, personal care products and life care products, among others. The Company also involves in wholesale and manufacture of drugs.
- Revenue in CNY (TTM)22.54bn
- Net income in CNY958.95m
- Incorporated2005
- Employees40.88k
- LocationLBX Pharmacy Chain JSCNo. 808, Qingzhuhu Road, Kaifu DistrictCHANGSHA 410152ChinaCHN
- Phone+86 73 184035189
- Fax+86 73 184035196
- Websitehttps://www.lbxdrugs.com/
More ▼
Mergers & acquisitions
| Acquired company | 603883:SHH since announced | Transaction value |
|---|---|---|
| Yangzhou Baixinyuan Pharmaceutical Chain Co Ltd | 35.73% | 29.38m |
Data delayed at least 15 minutes, as of May 17 2024.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZhuZhou QianJin Pharmaceutical Co., Ltd | 3.84bn | 322.70m | 4.91bn | 5.34k | 15.33 | 1.99 | -- | 1.28 | 0.7546 | 0.7546 | 8.94 | 5.82 | 0.8283 | 3.58 | 9.76 | 719,592.90 | 8.61 | 8.99 | 16.26 | 16.21 | 45.46 | 44.59 | 10.40 | 10.03 | 1.95 | -- | 0.1297 | 68.27 | -5.66 | 2.68 | 5.53 | 4.64 | -1.06 | -2.64 |
| JZJ Chain Drugstore Corp | 9.23bn | 390.37m | 6.64bn | 16.65k | 16.97 | 2.27 | -- | 0.7191 | 3.03 | 3.03 | 71.67 | 22.66 | 0.9457 | 2.51 | 17.64 | 554,255.80 | 4.01 | 5.75 | 7.38 | 11.17 | 35.83 | 35.21 | 4.24 | 5.04 | 0.312 | 4.42 | 0.6186 | 36.62 | 20.84 | 26.84 | 10.72 | 25.41 | 23.62 | -- |
| LBX Pharmacy Chain JSC | 22.54bn | 958.95m | 20.44bn | 40.88k | 21.31 | 2.89 | -- | 0.9071 | 1.64 | 1.64 | 38.53 | 12.08 | 1.06 | 3.61 | 11.24 | 551,261.10 | 5.40 | 5.73 | 11.29 | 12.96 | 32.73 | 32.33 | 5.11 | 5.08 | 0.4795 | 13.19 | 0.557 | 33.18 | 11.21 | 18.83 | 18.35 | 16.39 | -6.60 | 19.16 |
| Dashenlin Pharmaceutical Group Co Ltd | 25.34bn | 1.07bn | 26.13bn | 45.47k | 24.37 | 3.58 | -- | 1.03 | 0.9412 | 0.9412 | 22.41 | 6.41 | 1.09 | 3.84 | 23.18 | 557,261.80 | 4.99 | 6.57 | 10.07 | 12.63 | 34.87 | 37.51 | 4.58 | 5.54 | 0.6126 | 9.07 | 0.5772 | 45.67 | 15.45 | 22.59 | 12.63 | 17.02 | 26.51 | 6.85 |
| Yifeng Pharmacy Chain Co Ltd | 23.29bn | 1.48bn | 45.22bn | 39.65k | 30.52 | 4.34 | -- | 1.94 | 1.47 | 1.47 | 23.04 | 10.31 | 0.9795 | 4.01 | 12.79 | 587,438.10 | 6.93 | 6.93 | 12.89 | 12.47 | 37.74 | 38.73 | 7.07 | 6.71 | 0.9208 | 51.86 | 0.5012 | 26.56 | 13.59 | 26.72 | 11.57 | 27.66 | 25.93 | 33.54 |
Data as of May 17 2024. Currency figures normalised to LBX Pharmacy Chain JSC's reporting currency: Chinese Yuan Renminbi CNY
11.99%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 16.58m | 2.85% |
| Rongtong Fund Management Co., Ltd.as of 30 Sep 2023 | 11.01m | 1.89% |
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 10.66m | 1.83% |
| FIL Investment Management (Singapore) Ltd.as of 31 Mar 2024 | 6.41m | 1.10% |
| First Sentier Investors (UK) IM Ltd.as of 31 Jan 2024 | 5.09m | 0.87% |
| FIL Investment Management (Hong Kong) Ltd.as of 31 Mar 2024 | 4.88m | 0.84% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 4.23m | 0.73% |
| Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 4.00m | 0.69% |
| Essence Fund Co., Ltd.as of 31 Dec 2023 | 3.88m | 0.67% |
| First Sentier Investors (Hong Kong) Ltd.as of 31 Jan 2024 | 3.09m | 0.53% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
